共 98 条
[1]
Ohashi S(2015)Recent advances from basic and clinical studies of esophageal squamous cell carcinoma Gastroenterology 149 1700-1715
[2]
Miyamoto S(2011)Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis Lancet Oncol 12 681-692
[3]
Kikuchi O(2021)Comprehensive registry esophageal cancer in Japan, 2013 Esophagus 18 1-24
[4]
Sjoquist KM(2003)Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group—JCOG9204 J Clin Oncol 21 4592-4596
[5]
Burmeister BH(2012)A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907) Ann Surg Oncol 19 68-74
[6]
Smithers BM(2007)Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer N Engl J Med 357 1695-1704
[7]
Watanabe M(2006)Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325Study Group J Clin Oncol 24 4991-4997
[8]
Tachimori Y(2007)Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer Br J Cancer 96 432-438
[9]
Oyama T(2016)Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer Br J Cancer 115 1328-1334
[10]
Ando N(2018)Treatment and clinical outcome of clinical T4 esophageal cancer: a systematic review Ann Gastroenterol Surg 3 169-180